Literature DB >> 14673575

Variable reduction of caveolin-3 in patients with LGMD2B/MM.

Maggie C Walter1, Christian Braun, Matthias Vorgerd, Maja Poppe, Christian Thirion, Carolin Schmidt, Herbert Schreiber, Ursula I Knirsch, Dagmar Brummer, Wolfgang Müller-Felber, Dieter Pongratz, Josef Müller-Höcker, Angela Huebner, Hanns Lochmüller.   

Abstract

Mutations in the human dysferlin gene ( DYSF) cause autosomal recessive muscular dystrophies characterized by degeneration and weakness of proximal and/or distal muscles: limb girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM). Recently, an interaction between caveolin-3 and dysferlin in normal and dystrophic muscle (primary caveolin-3 deficiency; LGMD1C) was shown. In this study, clinical,morphological and genetic analysis was carried out in four independent LGMD2B/MM patients. All patients presented with an adult-onset, slowly progressive muscular dystrophy with variable involvement of proximal and distal muscles. We found complete lack of dysferlin in the four LGMD2B/MM patients. Secondary reduction of caveolin-3 was detected in three out of the four patients. Regular caveolae were detected along the basal lamina in two patients by electron microscopy. We provide further evidence that dysferlin and caveolin-3 interact in human skeletal muscle. It remains to be elucidated whether the loss of this interaction contributes to pathogenic events in muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673575     DOI: 10.1007/s00415-003-0234-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.

Authors:  Christian A Shaw; Nancy Larochelle; Roy W R Dudley; Hanns Lochmuller; Gawiyou Danialou; Basil J Petrof; George Karpati; Paul C Holland; Josephine Nalbantoglu
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

Review 3.  Translational research and therapeutic perspectives in dysferlinopathies.

Authors:  Florian Barthélémy; Nicolas Wein; Martin Krahn; Nicolas Lévy; Marc Bartoli
Journal:  Mol Med       Date:  2011-05-06       Impact factor: 6.354

Review 4.  [Limb girdle muscular dystrophies].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

5.  Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Authors:  Dirk Fischer; Maggie C Walter; Kristina Kesper; Jens A Petersen; Stefania Aurino; Vincenzo Nigro; Christian Kubisch; Thomas Meindl; Hanns Lochmüller; Kai Wilhelm; Horst Urbach; Rolf Schröder
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

6.  Reverse engineering gene network identifies new dysferlin-interacting proteins.

Authors:  Mafalda Cacciottolo; Vincenzo Belcastro; Steve Laval; Kate Bushby; Diego di Bernardo; Vincenzo Nigro
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

7.  Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Authors:  Ivana F Audhya; Antoinette Cheung; Shelagh M Szabo; Emma Flint; Conrad C Weihl; Katherine L Gooch
Journal:  J Neuromuscul Dis       Date:  2022

8.  New aspects on patients affected by dysferlin deficient muscular dystrophy.

Authors:  Lars Klinge; Ahmed Aboumousa; Michelle Eagle; Judith Hudson; Anna Sarkozy; Gianluca Vita; Richard Charlton; Mark Roberts; Volker Straub; Rita Barresi; Hanns Lochmüller; Kate Bushby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06-14       Impact factor: 10.154

Review 9.  Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies.

Authors:  Coralie Croissant; Romain Carmeille; Charlotte Brévart; Anthony Bouter
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.